Calidi Biotherapeutics, Inc.
CLDI · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22,209 | -$29,216 | -$25,427 | -$10,933 |
| Dep. & Amort. | $1,535 | $1,256 | $260 | $153 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,957 | $4,809 | $0 | $1,327 |
| Change in WC | -$1,698 | -$6,242 | $3,569 | $1,097 |
| Other Non-Cash | -$279 | $2,410 | $8,384 | $582 |
| Operating Cash Flow | -$19,694 | -$26,983 | -$13,214 | -$7,774 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$585 | -$428 | -$206 |
| Net Acquisitions | $0 | $9 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $190,011 | $0 |
| Other Inv. Act. | -$16 | $98 | -$190,077 | -$9 |
| Investing Cash Flow | -$16 | -$478 | -$494 | -$215 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,918 | $899 | $1,381 | $1,750 |
| Stock Issued | $18,065 | $2,763 | $10,764 | $35 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1,671 | $0 | $0 | $0 |
| Other Fin. Act. | $9,053 | $25,382 | -$58 | $8,025 |
| Financing Cash Flow | $27,365 | $29,044 | $12,087 | $9,810 |
| Forex Effect | -$13 | -$6 | $1,030 | -$4 |
| Net Chg. in Cash | $7,642 | $1,577 | -$591 | $1,817 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,167 | $590 | $1,063 | $420 |
| End Cash | $9,809 | $2,167 | $472 | $2,237 |
| Free Cash Flow | -$19,710 | -$27,568 | -$13,642 | -$7,980 |